Write in a clean editor, then format for JACC CardioOncology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JACC CardioOncology is a peer-reviewed journal published by Elsevier, covering Chemotherapy-induced cardiotoxicity and mitigation, Cardiac Imaging and Diagnostics, Amyloidosis: Diagnosis, Treatment, Outcomes.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, JACC CardioOncology 12 (2023) 45–58.
Formats any DOI in JACC CardioOncology style. No sign-up. |
| Publishes research in | Chemotherapy-induced cardiotoxicity and mitigation Cardiac Imaging and Diagnostics Amyloidosis: Diagnosis, Treatment, Outcomes Cancer Treatment and Pharmacology Cardiovascular Function and Risk Factors |
| ISSN | 2666-0873 |
| Citation impact (2-yr) | 6.32 |
| h-index | 62 |
| i10-index | 333 |
| Total citations | 15,630 |
| Article processing charge | $2,500 |
| Open access | Yes |
| Top institutions publishing here | University of Pennsylvania |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Cardiac masses are rare, but remain an important component of cardio-oncology practice. These include benign tumors, malignant tumors (primary and secondary) and tumor-like conditions (e.g., thrombus, Lambl's excrescences, and pericardial cyst). The advent of multimodality imaging has enabled identification of the etiology of cardiac masses in many cases, especially in conjunction with information from clinical…
Radiation therapy is an important component of cancer therapy for many malignancies. With improvements in cardiac-sparing techniques, radiation-induced cardiac dysfunction has decreased but remains a continued concern. In this review, we provide an overview of the evolution of radiotherapy techniques in thoracic cancers and associated reductions in cardiac risk. We also highlight data demonstrating that…
Radiation therapy is a cornerstone of cancer therapy, with >50% of patients undergoing therapeutic radiation. As a result of widespread use and improved survival, there is increasing focus on the potential long-term effects of ionizing radiation, especially cardiovascular toxicity. Radiation therapy can lead to atherosclerosis of the vasculature as well as valvular, myocardial, and pericardial…
OBJECTIVES: The goal of this study was to compare the risk of cardiotoxicity with osimertinib versus all other drugs and versus epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) (erlotinib, afatinib, and gefitinib) in the U.S. Food and Drug Administration Adverse Events Reporting System (FAERS), a pharmacovigilance database. BACKGROUND: Osimertinib has been shown to improve…
Immune checkpoint inhibitors (ICIs) are a major class of immuno-oncology therapeutics that have significantly improved the prognosis of various cancers, both in (neo)adjuvant and metastatic settings. Unlike other conventional therapies, ICIs elicit antitumor effects by enhancing host immune systems to eliminate cancer cells. There are 3 approved ICI classes by the U.S. Food and Drug…
